# Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

> **NCT00312000** · PHASE3 · COMPLETED · sponsor: **Dutch Colorectal Cancer Group** · enrollment: 820 (actual)

## Conditions studied

- Advanced Colorectal Cancer

## Interventions

- **DRUG:** capecitabine-irinotecan
- **DRUG:** capecitabine+irinotecan (1st line)

## Key facts

- **NCT ID:** NCT00312000
- **Lead sponsor:** Dutch Colorectal Cancer Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2006-02
- **Final completion:** 2006-12
- **Target enrollment:** 820 (ACTUAL)
- **Last updated:** 2008-09-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312000, "Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00312000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*